Advisor Group Holdings, Inc. Dbv Technologies S.A. Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.54 - $1.05 $398 - $774	-738 Reduced 86.32%	117 $0
Q4 2023 Feb 12, 2024	SELL	$0.7 - $1.33 $52 - $99	-75 Reduced 8.06%	855 $0
Q3 2023 Nov 13, 2023	SELL	$1.3 - $1.88 $85 - $124	-66 Reduced 6.63%	930 $1,000
Q2 2023 Aug 10, 2023	BUY	$1.42 - $2.23 $200 - $314	141 Added 16.49%	996 $1,000
Q2 2021 Aug 02, 2021	BUY	$5.32 - $6.53 $399 - $489	75 Added 9.62%	855 $4,000
Q4 2020 Feb 10, 2021	BUY	$1.38 - $3.01 $760 - $1,658	551 Added 240.61%	780 $2,000
Q3 2020 Nov 12, 2020	SELL	$1.58 - $4.77 $6,794 - $20,510	-4,300 Reduced 94.94%	229 $0
Q2 2020 Aug 14, 2020	SELL	$3.74 - $6.28 $23,775 - $39,921	-6,357 Reduced 58.4%	4,529 $20,000
Q1 2020 May 18, 2020	BUY	$2.33 - $12.98 $25,364 - $141,300	10,886 New	10,886 $43,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $745M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.